Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 2, 2004 - Issue 1
Submit an article Journal homepage
77
Views
48
CrossRef citations to date
0
Altmetric
Review

New trends in the management of tetanus

Deepthi Attygalle 108, Horton Place, Colombo 7, Sri Lanka. [email protected]
&
Nalini Rodrigo 108, Horton Place, Colombo 7, Sri Lanka. [email protected]
Pages 73-84 | Published online: 10 Jan 2014

References

  • Dietz V, Milstien JB, van Loon F, et al. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull. WHO 74,619–628 (1996).
  • Galazka A, Gasse F The present state of tetanus and tetanus vaccination. Carr. Top. MicrobioL I17717711fla 195,31-53 (1995).
  • Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice. A population based serologic survey of immunity to tetanus in the United States. N Engl.. 1. Med. 332, 761–766 (1995).
  • •Demonstrated the need for immunization of the elderly population which would significantly reduce mortality due to tetanus in the developed world.
  • Sutter RW, Cochi SL, Brink EW, Sirotkin BI. Assessment of vital statistics and surveillance data for monitoring tetanus mortality United States 1979–1984. Am.. 1. EpidernioL 131,132-142 (1990).
  • Rushdy AA, White JM, Ramsay ME, Crowcroft NS. Tetanus in England and Wales 1984-2000. Epiderniol. Infect. 130, 71–77 (2003).
  • Sharma N, Trubuhovich R, Thomas MG. Tetanus in Auckland: a preventable disease New Zealand Med. 107,82–84 (1994).
  • Pascual FB, McGinley EL, Zanardi LR, Cortese MM, Murphy TV. Tetanus surveillance — United States 1998–2000. MMWR CDC Surveill. Summ. 52(3), 1–8 (2003).
  • Bardenheier B, Prevots DR, Khetsuriani N, Wharton M. Tetanus surveillance — United States 1995–1997. MMWR CDC Surveill. Summ. 47(2), 1–13 (1998).
  • Prospero E, Appignanesi R, d'Enrico MM, Carle F. Epidemiology of tetanus in the Marshes Region of Italy 1992–1995. Bull WH076, 47–54 (1998).
  • Sun KO, Chan YVV, Cheung RTF, Therefore, PC, Yu YL, Li PK. Management of tetanus: a review of 18 cases.. 1. R. Soc. Med. 87,135-137 (1994).
  • Cherubin CE. The medical sequelae of narcotic addiction. Am. Intern. Med. 67, 23–33 (1967).
  • Ruben FL, Smith EA, Foster SO, et al. Simultaneous administration of smallpox, measles, yellow fever and diphtheria-pertussis and tetanus. Bull. WHO 48, 175–181 (1975).
  • Simonsen O. Vaccination against tetanus and diphtheria: evaluations of immunity in the Danish population, guidelines for vaccination and methods for control of vaccination programes. Dan. Med.. 1. 36, 24–47 (1989).
  • Ried PM, Brown D, Coni N, Sama A, Waters M. Tetanus immunization in the elderly population.. 1. Acc. Ernerg. Med. 13, 184–185 (1996).
  • Collingridge GL, Davies J. The in vitro inhibition of GABA release by tetanus toxin. Neuropharrnacology21,851-855 (1982).
  • Curtis DR, De Groat WC. Tetanus toxin and spinal inhibition Brain Res. 10,208–312 (1968).
  • Montecucco C, Schiavo G. Structure and function of tetanus and botulinum toxin. Quarterly Rev Biophys. 28,423–472 (1995).
  • Schiavo G, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransimitter release by proteolytic cleavage of synaptobrevin. Nature 359, 832–835 (1992).
  • Bleck TP, Tetanus: dealing with the continuing clinical challenge.. 1. Grit. Ill. 2, 41–52 (1987).
  • Mellanby J, Green J. How does tetanus toxin work? Neuroscience 6,281–300 (1981).
  • Dominghetti M, Savary G, Stricker H. Hyperadrenergic syndrome in severe tetanus: extreme rise in catecholamines responsive to labetalol. Br. Med. 288,1483–1484 (1984).
  • Rogers MD ed: Textbook of paediatric intensive care. Williams & Wilkins Philadelphia, PA, USA 866–75 (1987).
  • Trujillo MH, Castillo A, Espana J, Manzo A, Zerpa R. Impact of intensive care management on the prognosis of tetanus; analysis of 641 cases. Chest 920 (1), 63–65 (1987).
  • Sykes MK Intermittent positive pressure respiration in tetanus neonatorum. Anaesthesia 15,401–410 (1960).
  • Reis E, Friere E, Alexadrina S. Tetanus in an ICU in Portugal. International J. Intensive Care 1 120–121 (1994).
  • Senanayake N, Karallidde L. Tetanus. National Education Series No.8 (1985).
  • Burgess JA, Wambaugh GVV, Koczarski MJ. Report of case: reviewing cephalic tetanus. J. Am. Dent. Assoc. 123,67–70 (1992).
  • Apte NM, Karnad DR, Short report: spatula test: a simple bed side test to diagnose tetanus. Am.j of Trop. Med. Hyg. 53,386–387 (1995).
  • •Describes the spatula test as a useful clinical test for early diagnosis of tetanus.
  • Stoll BJ. Tetanus. Paed. Clinics N. America 26, 415–431 (1979).
  • Opravil M, Fierz W, Matter L, Blaser J, Luthy R. Poor antibody response after tetanus and pneumococcal vaccination in immunocopromised HIV infected patients. Clin. Exper. II77177111701. 84,185-189 (1991).
  • Jagoda A, Riggio S, Burguieres T Cephalic tetanus: a case report and review of the literature. Am. J. Ernerg. Med. 6,128–130 (1988).
  • Dutta TK, Padmanabhan S, Hamide A, Ramesh J. Localised tetanus mimicking incomplete transverse myelitis. Lancet 343, 983–984 (1994).
  • Sanders RKM, Joseph R, Martyn B, Peacock ML. Intrathecal antitetanus serum (horse) in the treatment of tetanus. Lancet I, 974–977 (1977).
  • Gupta PS, Kapoor R, Goyal S, Batra VK, Jain BK. Intrathecal human tetanus immunoglobulin in early tetanus. Lancetll, 439–440 (1980).
  • Abrutyn E, Berlin JA. Intrathecal therapy in tetanus: a meta analysis. JAMA 266(16), 2262–2267 (1991).
  • Vakil BJ, Armitage P, Clifford RE, Lawrence DR. Therapeutic trial of intracisternal human tetanus immunoglobulin in clinical tetanus. Trans. R. Soc. Trop. Med. Hyg. 73,579–583 (1979).
  • Neequaye J, Nkrumah FK, Failure of intrathecal antitetanus serum to improve survival in neonatal tetanus. Arch. Dis. Child. 58,276–278 (1983).
  • Chugh K, Seghal H. Evaluation of intrathecal human tetanus immunoglobin in tetanus neonatorum. Indian Pediatr. 22, 153–158 (1985).
  • Thomas PE, Cromwell EB, Mathew M. Intathecal antitetanus serum (ATS) and parenteral betamethazone in the treatment of tetanus. Trans. R. Soc. Trop. Med. Hyg. 76, 620–623 (1982).
  • Blake PA, Feldman RA, Buchanan TM. Brooks GF, Bennet JV. Serologic therapy of tetanus in the United States. JAMA 235, 42–44 (1976).
  • Clark G, Hill RG, Effects of a focal penicillin lesion on responses of rabbit cortical neurones to putative neurotransmitters. Br. Pharamacol. 44,435–441 (1972).
  • Ahmadsyah I, Salim A, Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. BE Med. J. 291,648–650 (1985).
  • •Establishes the status of metonidazole as the antibiotic of choice in tetanus.
  • Ablett JJL, Analysis and main experiences in 82 patients treated in the Leeds Tetanus Unit Symposium on tetanus in Great Britain, Boston Spa, UK National Lending Library (1967).
  • Edmondson RS, Flowers MW, Intensive care in tetanus: management, complications and mortality in 100 cases. Br. Med. J. 1, 1401–1404 (1979).
  • Phillips LA. A classification of tetanus. Lancet 1, 1261 (1965).
  • •Provides an insight into the methods of assessing severity both for prediction and for comparison between tetanus populations.
  • Yen LM, Dao LM, Day NP, et al. Role of quinine in the high mortality of intramuscular injection in tetanus. Lancet 344,786–787 (1994).
  • Lipman J, James MFM, Erskine J, Pitt ML, Eidelman J, Autonomic dysfunction in severe tetanus: magnesium sulfate as an adjunct to deep sedation. Grit. Care. Med. 15,987–988 (1987).
  • •A case report demonstrating the capacity of magnesium to lower catecholamine secretions in tetanus patients.
  • Guzman JA, Guerro A, Lopez-Obispo M, et al. Continuous perfusion with midazolam and atracurium in a patient with tetanus. Rev. Esp. Anestesiol. Reanirn 40(6), 375 (1993).
  • •Demonstrates the advantages of midazolam over diazepam for sedation in tetanus.
  • Gyasi HK, Fahr J, Kurian E, Mathew M. Midazolam for prolonged intravenous sedation in patients with tetanus. Mid. E. J. Anasth. 12,135–141 (1993).
  • •Demonstrates the advantages of midazolam over diazepam for sedation in tetanus.
  • Peduto VA, Pinsau GM, Piga M, Midazolam, propofol and clonidine for sedation and control of autonomic dysfunction in severe generalized tetanus. Minerva Anestesiol. 59,171–178 (1993).
  • Borgeat A, Dessigbourg C, Rochani M, Suter PM. Sedation by propofol in tetanus — is it a muscular relaxant? Intensive Care Med. 17,427–429 (1991).
  • •Case report demonstrating that propofol can reduce hospital stay for tetanus patients.
  • Borgeat A, Popovic V, Schwander D. Efficacy of a continuous infusion of propofol in a patient with tetanus. Grit. Care Med. 19, 295–297 (1991).
  • Dance M. Tetanus: an intensivist's view. Internat.J. Intensive Cam 1,56–60 (1994).
  • Powles AB, Ganta R. Use of vecuronium in the management of tetanus. Anaesthesia 40, 879–881 (1985).
  • Fischer JR, Baer RK, Acute myopathy associated with combined use of cortico-steroids and neuromuscular blocking agents. Ann. Pharmacother. 30,1437–1445 (1996).
  • Peat SJ, Potter DR, Hunter PI. Prolonged use of atracurium in a patient with tetanus. Anaesthesia 43,962–963 (1988).
  • Rose AG. Catecholamine induced myocardial damage associated with phaeochromocytoma and tetanus. S. Afr. Med. J. 48,1285–1289 (1974).
  • •Paper showing the importance of reducing catecholamine secretions rather than blocking them at the level of the receptor.
  • Hollow VM, Clarke GM. Autonomic manifestations of tetanus. Anaesth. Intensive Care3, 142–147 (1975).
  • Pinder M Controversies in the management of tetanus. Intensive Care Med. 14,129–143 (1997).
  • •A critical review of drugs used for autonomic dysfunction in tetanus.
  • Kerr JH, Corbett JL, Prys-Roberts C, Crampton Smith A, Spalding JMK. Involvement of the sympathetic nervous system in tetanus. Studies on 82 cases. Lancet 2,236–241 (1968).
  • Prys Roberts C. Corbett JL, Kerr JH. Treatment of sympathetic activity in tetanus. Lancet 1,542–546 (1969).
  • Buchanan, N, Smit L, Cane RD, De Andrade M, Sympathetic overactivity in tetanus: fatality associated with propranolol. Br. Med. J. 2,254–255 (1978).
  • Udwadia FE, Sunavala JD, Jain MC, et al. Haemodynamics studies during the management of severe tetanus. Q. j Med. 83(302), 449–460 (1992).
  • •Provides an understanding of the physiological mechanisms causing autonomic dysfunction in tetanus patients.
  • Wesley AG, Hariparsad D, Pather M, Rocke DA. Labetelol in tetanus. The treatment of sympathetic nervous system over activity. Anaesthesia 38,243–249 (1983).
  • King WW Cave DR. Use of esmolol to control autonomic instability of tetanus. Am.j Med. 91, 4252— 4258 (1991).
  • Rocke DA, Wesley AG, Pather M, Calver AD, Harispasad D. Morphine in tetanus — the management of sympathetic nervous system overactivity. S. Af Medl. j 70, 666–668 (1986).
  • Buchanan N, Cane RD, Wolfson G, De Andrade M. Autonomic dysfunction in tetanus: the effects of a variety of therapeutic agents with special reference to morphine. Intensive Care Med. 5,65–68 (1979).
  • Sutton DN, Tremlett MR, Woodcock TE, Nielsen MS. Management of autonomic dysfunction in severe tetanus: the use of magnesium sulfate and clonidine. Intensive Care Med. 16,75–80 (1990).
  • Brown JL, Sinding H, Mathias CJ. Autonomic disturbances in severe tetanus: failure of parenteral clonidine to control blood pressure j Infect. 29(1), 67–71 (1994).
  • Altura BM, Altura BT. General Anaesthetics and Magnesium Ions as Calcium Antagonists on Vascular Smooth Muscle. Weiss GB Ed.: New perspectives on calcium antagonists. American Physiological Society, MD, USA 131–145 (1981).
  • Douglas WW, Rubin RP. The mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulus secretion coupling. j Physiol. 167,288–310 (1973).
  • Lishajko F. Releasing effect of calcium and phosphate on catecholamines, ATP and protein from chromaffin cell granules. Acta Physiologica Scandinavica 79,575–584 (1970).
  • Von Euler VS, Lishajko F. Effects of Mg++ and Ca++ on noradrenaline release and uptake in adrengic nerve granules in different media. Acta Physiologica Scandinavica 89,415–522 (1973).
  • James MFM. Use of magnesium sulfate in the anaesthetic management of phaechromocytoma: a review of 17 anaesthetics. Br. j Anaesth. 62,616–623 (1989).
  • James MFM, Manson EDM. The use of magnesium sulfate infusions in the management of very severe tetanus. Intensive Care Med. 11,5–12 (1985).
  • Delport SD, Neonatal tetanus — an opportunity for prevention. S. Afr. Med. J. 77,78–79 (1990).
  • Checketts MR, White RJ. Avoidance of intermittent positive pressure ventilation in tetanus with dantrolene therapy. Anaesthesia 48(11), 969–971 (1993).
  • Muller H, Borner U, Zierski J, Hempelmann G. Intra thecal baclofen for treatment of tetanus-induced spasticity. Anaesthesiology66, 76–79 (1987).
  • Saissy JM, Demaziere J, Vitris M, Marcoux L, et al. Treatment of severe tetanus by intrathecal injections of baclofen without artificial ventilation. Intensive Care Med. 18(4) 241–244 (1992).
  • Lee C Zhang, Kwan WE Electromyographic and mechanomyographic characteristics of neuromuscular block by magnesium sulfate in the pig. Br. J. Anaesth. 76,278–283 (1996).
  • •Demonstrates why magnesium sulphate controls spasms but spares the respiratory muscles.
  • Attygalle D, Rodrigo N. Magnesium sulfate for control of spasms in severe tetanus. Anaesthesia 52,956–962 (1997).
  • Attygalle D, Rodrigo N. Magnesium as first line therapy in the management of tetanus: a prospective study. Anaesthesia 57, 811–817 (2002).
  • ••A report of patients treated withmagnesium sulphate in tetanus controlling spasms and SOA while minimizing ventilatory support and avoiding sedation. A protocol for magnesium treatment in tetanus is provided.
  • Ramanathan J, Sibai BM, Duggirala V, Maduska AL. Pulmonary function in pre eclamptic women receiving MagnesiumS0A. j Reprod. Med. 33,432–435 (1988).
  • •Paper showing the reduction of vital capacity by magnesium therapy.
  • William S. Use of magnesium to treat tetanus. Br. j Anaesth. 88,152–153 (2001).
  • Foca A, Rotiroti D, Mastroeni P, Nistico G. Effects of tetanus toxin after intracerbral microinjection are antagonized by drugs enhancing GABAergic transmission in adult fowl. Neuropharrnaco/ogy23, 155–158 (1984).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.